Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Research From Scottsdale Radiation Oncologist, Dr. Robert Kuske, Presents Important Data in Stage 0,1, or 2 Breast Cancer at the 2018 San Antonio Breast Cancer Symposium
By: PR Newswire Association LLC. - 11 Dec 2018Back to overview list

SCOTTSDALE, Ariz., Dec. 11, 2018 /PRNewswire/ -- Research from one of Scottsdale-based Arizona Breast Cancer Specialists' founders (a division of Arizona Center for Cancer Care), Robert Kuske, MD, was presented at the 2018 San Antonio Breast Cancer Symposium held December 4-8. The data suggests that a 5-day course of radiation treatment known as Partial Breast Irradiation (PBI) may be an acceptable alternative to the traditional 6-week course of Whole Breast Irradiation (WBI).  There was no statistically significant difference between Partial Breast Irradiation (PBI) and Whole Breast Irradiation (WBI) giving breast cancer patients the option for a shorter course of treatment. The reoccurrence rate in the breast was less than 1% difference between the two techniques. More women from Arizona were enrolled in this key trial than from any other state in the country.

According to Dr. Kuske, "This study will change the practice of medicine worldwide because there are fewer long-term side effects and much greater convenience with this 5-day treatment of breast cancer."

A radiation oncologist passionate about helping women with breast cancer, Dr. Kuske pioneered "accelerated partial breast irradiation," known as Brachytherapy, a five-day alternative to the conventional six weeks of external beam whole breast irradiation in select early-stage breast cancer. Brachytherapy also spares the lung and heart from radiation exposure. He is a leader of the important 4300 patient phase III trial through the National Cancer Institute. He is recognized for his work that allows women who have been augmented with breast implants to be successfully treated with lumpectomy and 5-day radiation without hardening of the implants. Dr. Kuske is one of only a dozen radiation doctors in the U.S. who restrict their practice to breast cancer and publish extensively in medical literature. He was honored as the top medical researcher in the Valley.

For more information, press only:

Jenny Martin  
414-378-8703
Jenny.martin@arizonaccc.com

For more information on Product:

http://www.arizona-breast-cancer-specialists.com/index.html

Cision View original content:http://www.prnewswire.com/news-releases/research-from-scottsdale-radiation-oncologist-dr-robert-kuske-presents-important-data-in-stage-0-1--or-2-breast-cancer-at-the-2018-san-antonio-breast-cancer-symposium-300763561.html

SOURCE Arizona Breast Cancer Specialists

Copyright 2018 PR Newswire Association LLC. Back to overview list
to the top ↑